Israel-U.S. – Health Innovation Dialogue

Introduction (5 minutes) – Khush Choksy, Senior Vice President, Middle East Affairs, U.S. Chamber of Commerce Keynotes: Building A Stronger U.S.-Israel Health Relationship (15 minutes) – Dr. Asher Salmon, Director, International Relations Division, Israel Ministry of Health, Dr. Rachel Levine, Assistant Secretary of Health, U.S. Department of Health and Human Services Moderated Discussion: (10 minutes) – with Representative Chris Pappas (D-NH) Moderator: Ileana Ros-Lehtinen, Senior Advisor, Akin Gump, Former Chairwoman, House Foreign Affairs Committee

Digital (mobile) health technology offers many potential opportunities for clinical trials, including the acquisition of frequent or continuous data directly from patients wherever they are. This session will explore the opportunities to measure drug efficacy in clinical trials using sensor and other technologies. The session will also address some of the challenges to the widespread implementation of mobile health and explore opportunities to continue to improve the landscape for bilateral commercial health cooperation. Dr. Osnat Luxenburg, Head of the Medical Technology, Innovation, Health Information, and Research Directorate, IL Ministry of Health Dr. Leonard Sacks, Associate Director for Clinical Methodology, Office of Medical Policy, U.S. Food and Drug Administration (FDA) Professor Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer, Sheba Medical Center Trevor Gunn, Vice President, International Relations, Medtronic Moderator: Esti Shelly, Head of the Digital Health Division, Israel’s Ministry of Health

This session would focus on the newly emerging area in health contributing to major advances and progress in a range of health challenges. Look at Israel’s National Bio-convergence Initiative and understand developments in the U.S. government and private sector around bio-convergence. Dr. Christopher Houchens, Director Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA) Dr. Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer Dr. Sheng Lin-Gibson, Chief of the Biosystems and Biomaterials Division, National Institute for Standards and Technology (NIST) Moderator: Anya Eldan, VP Startup Division and Business Development, Israel Innovation Authority

Panelists will present innovation platforms for collaboration in the healthtech domain, including the Medical Technology Enterprise Consortium (MTEC) and the Thomas Jefferson Israel Center. These new models demonstrate public-private partnerships in U.S.-Israel health innovation and cooperation and provide practical insights on expanding cooperation in this important sector. Bill Howell, President, Medical Technology Enterprise Consortium (MTEC) Dr. Zvi Grunwald, CEO, Jefferson Israel Center Moderator: Nili Shalev, VP International Division, Israel Innovation Authority

Josh Kram, Managing Director, U.S.- Israel Business Council, U.S. Chamber of Commerce